This agrees with our previous study showing that BRAFV600E inhibitors induce epithelial differentiation markers such as Claudin-15, AMACR, and carboxyesterases (Ces) in human CRC cell lines [10]. The gene discussed is CLDN15; the disease is colorectal carcinoma.